Jeremy Green, 10% Owner, Director at IGM Biosciences, Inc. (IGMS), bought 2,608,695 shares at $23.00 ($60.0M) on 2022-04-01, disclosed to the SEC on 2022-04-04.
Open-market purchase of $60.0M IGMS by 10% Owner, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ADCT | BUY | 2024-12-13 | $419K | — | Filing → |
| STTK | BUY | 2024-12-06 | $333K | — | Filing → |
| STTK | SELL | 2024-12-06 | $333K | — | Filing → |